Mason Carrico
Stock Analyst at Stephens & Co.
(0.51)
# 3,064
Out of 4,413 analysts
45
Total ratings
16.67%
Success rate
-23.26%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DMTK DermTech | Reiterates: Equal-Weight | $1.5 | $0.62 | +143.11% | 4 | Apr 19, 2024 | |
| OCX OncoCyte | Reiterates: Equal-Weight | $4 | $2.55 | +56.86% | 3 | Apr 17, 2024 | |
| CDNA CareDx | Reiterates: Overweight | $15 | $9.18 | +63.40% | 7 | Apr 17, 2024 | |
| ILMN Illumina | Reiterates: Overweight | $170 | $124.68 | +36.35% | 3 | Apr 10, 2024 | |
| NTRA Natera | Reiterates: Overweight | $78 | $94.15 | -17.15% | 3 | Jan 30, 2024 | |
| PACB Pacific Biosciences of California | Initiates: Overweight | $11 | $1.69 | +550.89% | 1 | Dec 14, 2023 | |
| CTKB Cytek Biosciences | Initiates: Overweight | $9 | $6.37 | +41.29% | 1 | Dec 14, 2023 | |
| AKYA Akoya Biosciences | Maintains: Overweight | $14 → $9 | $3.96 | +127.27% | 4 | Nov 13, 2023 | |
| VCYT Veracyte | Reiterates: Overweight | $34 | $20.13 | +68.90% | 5 | Oct 10, 2023 | |
| CSTL Castle Biosciences | Reiterates: Overweight | $37 | $22.02 | +68.03% | 5 | Jul 6, 2023 | |
| TXG 10x Genomics | Reiterates: Overweight | $65 | $26.92 | +141.46% | 3 | May 18, 2023 | |
| MYGN Myriad Genetics | Reiterates: Equal-Weight | $24 | $19.47 | +23.27% | 3 | May 4, 2023 | |
| GH Guardant Health | Reiterates: Overweight | $63 | $18.26 | +245.02% | 3 | Feb 16, 2023 |
DermTech
Apr 19, 2024
Reiterates: Equal-Weight
Price Target: $1.5
Current: $0.62
Upside: +143.11%
OncoCyte
Apr 17, 2024
Reiterates: Equal-Weight
Price Target: $4
Current: $2.55
Upside: +56.86%
CareDx
Apr 17, 2024
Reiterates: Overweight
Price Target: $15
Current: $9.18
Upside: +63.40%
Illumina
Apr 10, 2024
Reiterates: Overweight
Price Target: $170
Current: $124.68
Upside: +36.35%
Natera
Jan 30, 2024
Reiterates: Overweight
Price Target: $78
Current: $94.15
Upside: -17.15%
Pacific Biosciences of California
Dec 14, 2023
Initiates: Overweight
Price Target: $11
Current: $1.69
Upside: +550.89%
Cytek Biosciences
Dec 14, 2023
Initiates: Overweight
Price Target: $9
Current: $6.37
Upside: +41.29%
Akoya Biosciences
Nov 13, 2023
Maintains: Overweight
Price Target: $14 → $9
Current: $3.96
Upside: +127.27%
Veracyte
Oct 10, 2023
Reiterates: Overweight
Price Target: $34
Current: $20.13
Upside: +68.90%
Castle Biosciences
Jul 6, 2023
Reiterates: Overweight
Price Target: $37
Current: $22.02
Upside: +68.03%
10x Genomics
May 18, 2023
Reiterates: Overweight
Price Target: $65
Current: $26.92
Upside: +141.46%
Myriad Genetics
May 4, 2023
Reiterates: Equal-Weight
Price Target: $24
Current: $19.47
Upside: +23.27%
Guardant Health
Feb 16, 2023
Reiterates: Overweight
Price Target: $63
Current: $18.26
Upside: +245.02%